L04AA36 ocrelizumab
ATC group of level 5 – chemical substance · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases
This site has the patient leaflet or the SPC of 1 medicine in this group.
- 1 prescription only (POM)
Active substance: Ocrelizumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L04 Immunosuppressants 545 medicines
- L04A Immunosuppressants 543 medicines
- L04AA Selective immunosuppressants 115 medicines
- L04AA36 ocrelizumab 1 medicine
- L04AA Selective immunosuppressants 115 medicines
- L04A Immunosuppressants 543 medicines
- L04 Immunosuppressants 545 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Ocrevus 300 mg concentrate for solution for infusion SPC | Prescription only (POM) |
Other groups of the same level
- L04AA03 antilymphocyte immunoglobulin (horse) 1 medicine
- L04AA04 antithymocyte immunoglobulin (rabbit) 1 medicine
- L04AA06 mycophenolic acid 26 medicines
- L04AA10 sirolimus 4 medicines
- L04AA13 leflunomide 18 medicines
- L04AA18 everolimus 3 medicines
- L04AA21 efalizumab 1 medicine
- L04AA23 natalizumab 2 medicines
- L04AA24 abatacept 5 medicines
- L04AA25 eculizumab 1 medicine
- L04AA26 belimumab 3 medicines
- L04AA27 fingolimod 12 medicines
- L04AA28 belatacept 1 medicine
- L04AA29 tofacitinib 3 medicines
- L04AA31 teriflunomide 1 medicine
- L04AA32 apremilast 10 medicines
- L04AA33 vedolizumab 3 medicines
- L04AA34 alemtuzumab 2 medicines
- L04AA37 baricitinib 1 medicine
- L04AA38 ozanimod 3 medicines
- L04AA40 cladribine 2 medicines
- L04AA41 imlifidase 1 medicine
- L04AA42 siponimod 2 medicines
- L04AA43 ravulizumab 2 medicines
- L04AA44 upadacitinib 2 medicines
- L04AA45 filgotinib 2 medicines
Other names of the ATC group
- German: L04AA36 Ocrelizumab
- Spanish: L04AA36 OCRELIZUMAB
- German: L04AA36 Ocrelizumab
- Italian: L04AA36 OCRELIZUMAB
- Polish: L04AA36 OKRELIZUMAB
- Turkish: L04AA36 okrelizumab
- Portuguese (Brazil): L04AA36 Ocrelizumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L04AA36
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.